Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer

NCT00039455 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

50

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

HER2-positive Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: alvocidib
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)